Dalcor taps new CEO Fouzia Laghrissi-Thode as pivotal PhIII looms; Kelly Martin settles in at Novan; Edward Stewart takes over Commense
→ AstraZeneca vet Fouzia Laghrissi-Thode will be leading DalCor Pharmaceuticals through patient enrollment into its pivotal Phase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.